Effects of the APOE ε2 allele on mortality and cognitive function in the oldest old

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 4, 2013, Pages 389-394

  Lindahl Jacobsen, Rune ^a   Tan, Qihua ^a   Mengel From, Jonas ^a   Christensen, Kaare ^a,b   Nebel, Almut ^c   Christiansen, Lene ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Aging; APOE; Cognitive function; Mortality; Oldest old

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ARTICLE; COGNITIVE DEFECT; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INTELLIGENCE TEST; MALE; MORTALITY; RISK FACTOR; VERY ELDERLY;

AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; COGNITION DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTELLIGENCE TESTS; MALE; MORTALITY; RISK FACTORS;

MLCS; MLOWN;

EID: 84875162102     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls192     Document Type: Article

References (38)

1. Herskind AM, McGue M, Holm NV, Sørensen TI, Harvald B, Vaupel JW. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet. 1996;97:319-323.
2. Skytthe A, Pedersen NL, Kaprio J, et al. Longevity studies in GenomEUtwin. Twin Res. 2003;6:448-454.
3. Jacobsen R, Martinussen T, Christiansen L, et al. Increased effect of the ApoE gene on survival at advanced age in healthy and long-lived Danes: two nationwide cohort studies. Aging Cell. 2010;9:1004-1009.
4. Hjelmborg JvB, Iachine I, Skytthe A, et al. Genetic influence on human lifespan and longevity. Hum Genet. 2006;119:312-321.
5. Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet. 2006;7:436-448.
6. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
7. Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet. 1984;65:237-241.
8. Vogt MT, Cauley JA, Kuller LH. Apolipoprotein E phenotype, arterial disease, and mortality among older women: the study of osteoporotic fractures. Genet Epidemiol. 1997;14:147-156.
9. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA. 1994;272:1666-1671.
10. Berlau DJ, Corrada MM, Head E, Kawas CH. APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology. 2009;72:829-834.
11. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155:487-495.
12. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L. APOE-related mortality: effect of dementia, cardiovascular disease and gender. Neurobiol Aging. 2009;30:1545-1551.
13. Huang X, Chen PC, Poole C. APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology. 2004;62:2198-2202.
14. Benjamin R, Leake A, McArthur FK, et al. Protective effect of APOE ε2 in Alzheimer's disease. Lancet. 1994;344:473.
15. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
16. Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD. Apolipoprotein ε2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology. 1997;48:515-519.
17. West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein ε2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett. 1994;175:46-48.
18. Helkala EL, Koivisto K, Hanninen T, et al. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci Lett. 1996;204:177-180.
19. Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, Bennett DA. The apolipoprotein ε2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatr. 2002;73:672-677.
20. Bathum L, Christiansen L, Jeune B, Vaupel J, McGue M, Christensen K. Apolipoprotein e genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians. J Am Geriatr Soc. 2006;54:654-658.
21. Engberg H, Christensen K, Andersen-Ranberg K, Jeune B. Cohort changes in cognitive function among Danish centenarians. A comparative study of 2 birth cohorts born in 1895 and 1905. Dement Geriatr Cogn Disord. 2008;26:153-160.
22. Nybo H, Gaist D, Jeune B, et al. The Danish 1905 cohort: a geneticepidemiological nationwide survey. J Aging Health. 2001;13:32-46.
23. McGue M, Christensen K. The heritability of level and rate-of-change in cognitive functioning in Danish twins aged 70 years and older. Exp Aging Res. 2002;28:435-451.
24. McGue M, Christensen K. The heritability of cognitive functioning in very old adults: evidence from Danish twins aged 75 years and older. Psychol Aging. 2001;16:272-280.
25. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53:441-449.
26. Breslow NE, Day NE. Statistical Methods in Cancer Research. The Design and Analysis of Cohort Studies, Vol. II. Lyon, France: International Agency for Research on Cancer; 1987.
27. Corder EH, Lannfelt L, Viitanen M, et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol. 1996;53:418-422.
28. Hayden KM, Zandi PP, Lyketsos CG, et al. Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc. 2005;53:935-942.
29. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc. 1998;46:712-715.
30. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the ε2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci. 2001;56:M75-M78.
31. Koivisto AM, Lempiäinen P, Koivisto K, et al. Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study. Neuroepidemiology. 2000;19:327-332.
32. Slooter AJ, Cruts M, Van Broeckhoven C, Hofman A, van Duijin CM. Apolipoprotein E and longevity: the Rotterdam Study. J Am Geriatr Soc. 2001;49:1258-1259.
33. Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ. 1994;309:1202-1206.
34. Skoog I, Hesse C, Aevarsson O, et al. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatr. 1998;64:37-43.
35. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemiol. 2002;22:146-155.
36. Louhija J, Viitanen M, Agüero-Torres H, Tilvis R. Survival in Finnish centenarians in relation to apolipoprotein E polymorphism. J Am Geriatr Soc. 2001;49:1007-1008.
37. Nicoll JA, Savva GM, Stewart J, et al. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales. Neuropathol Appl Neurobiol. 2011;37:285-294.
38. Love S, Siew LK, Dawbarn D, Wilcock GK, Ben-Shlomo Y, Allen SJ. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol Aging. 2006;27:797-803.